ACOMS+ 및 학술지 리포지터리 설명회

  • 한국과학기술정보연구원(KISTI) 서울분원 대회의실(별관 3층)
  • 2024년 07월 03일(수) 13:30
 

  • P-ISSN1225-0163
  • E-ISSN2288-8985
  • SCOPUS, ESCI, KCI

논문 상세

Home > 논문 상세
  • P-ISSN 1225-0163
  • E-ISSN 2288-8985

An HPLC method for the determination of thioctic acid in raw material and tablets

분석과학 / Analytical Science and Technology, (P)1225-0163; (E)2288-8985
2017, v.30 no.5, pp.221-225
https://doi.org/10.5806/AST.2017.30.5.221
Xuan Lan Mai (강원대학교)
김경호 (강원대학교)
안계찬 (강원대학교)
이석한 (강원대학교)
강종성 (충남대학교)
우미희 (대구가톨릭대학교)
나동희 (중앙대학교)
전인구 (The Society of Korean Official Compendium for Public Health)
  • 다운로드 수
  • 조회수

Abstract

Thioctic acid is a vitamin-like antioxidant which is prepared as tablets and injection. The Korean Pharmacopoeia (KP XI) contains monograph for the quality control of raw thioctic acid using ultra-violet visible spectrophotometry and its formulations using high performance liquid chromatography (HPLC). In British Pharmacopoeia 2013 (BP2013), another HPLC method is used for the assay test of thioctic acid material. For the international harmonization, we present an HPLC method for quantitation of thioctic acid in both raw material and tablets. Method validation was performed to determine linearity, precision, accuracy, system suitability, and robustness. The linearity of calibration curves in the desired concentration range was high (r2 = 0.9995), while the RSDs for intra- and inter-day precision were 0.93 ~ 1.26 % and 1.40 ~ 1.76 %, respectively. Accuracies ranged from 98.13-100.00 %. Since the system suitability, intermediate-precision and robustness of the assay were satisfactory, this method will be a valuable addition to the Korean Pharmacopoeia (KP XI).

keywords
HPLC, thioctic acid, assay, validation, tablet dosage form


참고문헌

1

1. Human Metabolome Database, http://www.hmdb.ca/metabolites/HMDB01451.

2

2. Ministry of Food and Drug Safety, The Korean Pharmacopoeia, 11th Edition, Republic of Korea (2014).

3

3. The United States Pharmacopeial Convention, The United States Pharmacopeia, USP 39 NF 34, United States (2016).

4

4. The Ministry of Health, Labour and Welfare, The Japanese Pharmacopoeia, 17th Edition, Japan (2016).

5

5. Medicines & Healthcare Products Regulatory Agency, British Pharmacopoeia, 7th Edition, United Kingdom (2013).

6

6. ICH Guideline. Q2(R1): validation of Analytical Procedures: Text and Methodology Q2(R1) in ICH Harmonised Tripartite Guideline (2005).

7

7. Ministry of Food and Drug Safety No. 2009-173 (2009.12. 15), Republic of Korea.

8

8. Ministry of Food and Drug Safety, No. C0-2012-2-005(2012. 09. 19), Republic of Korea.

상단으로 이동

분석과학